Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case report-Reference-Cited by-同舟云学术

Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case report

Published:2010-12 Issue:1 Volume:9 Page:
ISSN:1744-859X
Container-title:Annals of General Psychiatry
language:en
Short-container-title:Ann Gen Psychiatry

Author:

Fornaro Michele,Martino Matteo

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1186/1744-859X-9-39.pdf

Reference18 articles.

1. Alonso P, Menchon JM, Segalas C, Jaurrieta N, Jimenez-Murcia S, Cardoner N, Labad J, Real E, Pertusa A, Vallejo J: Clinical implications of insight assessment in obsessive-compulsive disorder. Compr Psychiatry. 2008, 49: 305-312. 10.1016/j.comppsych.2007.09.005.

2. Fornaro M, Gabrielli F, Albano C, Fornaro S, Rizzato S, Mattei C, Solano P, Vinciguerra V, Fornaro P: Obsessive-compulsive disorder and related disorders: a comprehensive survey. Ann Gen Psychiatry. 2009, 8: 13-10.1186/1744-859X-8-13.

3. Huska MT, Catalano G, Catalano MC: Serotonin syndrome associated with the use of escitalopram. CNS Spectr. 2007, 12: 270-274.

4. Lader M: Pharmacotherapy of mood disorders and treatment discontinuation. Drugs. 2007, 67: 1657-1663. 10.2165/00003495-200767120-00001.

5. American Psychiatric Association: American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders Compendium 2006. 2006, Arlington, VA: American Psychiatric Publishing

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial;BMC Pharmacology and Toxicology;2022-09-27

2. Should Olanzapine be Advocated Over Conventional Anti-Emetics for the Prevention of Chemotherapy-Induced Nausea and Vomiting? An Updated Meta-Analysis of Randomized Control Trials;Current Enzyme Inhibition;2019-10-19

3. Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial;Journal of Psychopharmacology;2019-10-01

4. Are 5-HT3antagonists effective in obsessive-compulsive disorder? A systematic review of literature;Human Psychopharmacology: Clinical and Experimental;2015-02-10